[PHARMA] YoY Quarter Result on 31-Dec-2010 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
25-Feb-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2010
Quarter
31-Dec-2010 [#4]
Profit Trend
QoQ- -126.28%
YoY- -110.29%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Revenue 567,860 482,404 367,786 376,116 323,906 328,243 292,817 11.65%
PBT 33,007 4,248 16,368 -2,701 27,490 24,496 23,572 5.76%
Tax -11,740 -11,716 -4,186 749 -5,372 -6,574 -7,125 8.67%
NP 21,267 -7,468 12,182 -1,952 22,118 17,922 16,447 4.37%
-
NP to SH 20,813 -7,934 11,942 -2,256 21,914 17,789 16,069 4.40%
-
Tax Rate 35.57% 275.80% 25.57% - 19.54% 26.84% 30.23% -
Total Cost 546,593 489,872 355,604 378,068 301,788 310,321 276,370 12.02%
-
Net Worth 486,672 472,037 514,153 421,262 431,217 388,298 349,837 5.65%
Dividend
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Div 16,049 11,771 35,296 - 39,590 28,881 19,257 -2.98%
Div Payout % 77.11% 0.00% 295.57% - 180.66% 162.36% 119.84% -
Equity
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Net Worth 486,672 472,037 514,153 421,262 431,217 388,298 349,837 5.65%
NOSH 258,868 117,715 117,655 106,919 107,001 106,969 106,984 15.85%
Ratio Analysis
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
NP Margin 3.75% -1.55% 3.31% -0.52% 6.83% 5.46% 5.62% -
ROE 4.28% -1.68% 2.32% -0.54% 5.08% 4.58% 4.59% -
Per Share
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 219.36 409.81 312.60 351.78 302.71 306.86 273.70 -3.61%
EPS 8.04 -6.74 10.15 -2.11 20.48 16.63 15.02 -9.88%
DPS 6.20 10.00 30.00 0.00 37.00 27.00 18.00 -16.26%
NAPS 1.88 4.01 4.37 3.94 4.03 3.63 3.27 -8.80%
Adjusted Per Share Value based on latest NOSH - 106,919
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
RPS 39.40 33.47 25.52 26.10 22.47 22.78 20.32 11.65%
EPS 1.44 -0.55 0.83 -0.16 1.52 1.23 1.11 4.42%
DPS 1.11 0.82 2.45 0.00 2.75 2.00 1.34 -3.08%
NAPS 0.3377 0.3275 0.3567 0.2923 0.2992 0.2694 0.2427 5.65%
Price Multiplier on Financial Quarter End Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 31/12/13 31/12/12 30/12/11 30/12/10 31/12/09 31/12/08 31/12/07 -
Price 4.45 8.10 5.36 5.31 4.00 3.36 2.93 -
P/RPS 2.03 1.98 1.71 1.51 1.32 1.09 1.07 11.25%
P/EPS 55.35 -120.18 52.81 -251.66 19.53 20.20 19.51 18.96%
EY 1.81 -0.83 1.89 -0.40 5.12 4.95 5.13 -15.92%
DY 1.39 1.23 5.60 0.00 9.25 8.04 6.14 -21.91%
P/NAPS 2.37 2.02 1.23 1.35 0.99 0.93 0.90 17.49%
Price Multiplier on Announcement Date
31/12/13 31/12/12 31/12/11 31/12/10 31/12/09 31/12/08 31/12/07 CAGR
Date 24/02/14 18/02/13 22/02/12 25/02/11 19/02/10 27/02/09 28/02/08 -
Price 4.29 7.80 5.90 5.35 4.05 2.73 2.98 -
P/RPS 1.96 1.90 1.89 1.52 1.34 0.89 1.09 10.26%
P/EPS 53.36 -115.73 58.13 -253.55 19.78 16.42 19.84 17.90%
EY 1.87 -0.86 1.72 -0.39 5.06 6.09 5.04 -15.21%
DY 1.45 1.28 5.08 0.00 9.14 9.89 6.04 -21.14%
P/NAPS 2.28 1.95 1.35 1.36 1.00 0.75 0.91 16.52%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment